Dana R - Search Results

1

Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders.

Singh RB, Naderi A, Cho W, Ortiz G, Musayeva A, Dohlman TH, Chen Y, Ferrari G, Dana R. Singh RB, et al. Among authors: dana r. Ocul Surf. 2022 Jul;25:142-153. doi: 10.1016/j.jtos.2022.06.007. Epub 2022 Jun 30. Ocul Surf. 2022. PMID: 35779793 Free PMC article. Review.

2

Chronic ocular surface disease after allogeneic bone marrow transplantation.

Balaram M, Rashid S, Dana R. Balaram M, et al. Among authors: dana r. Ocul Surf. 2005 Oct;3(4):203-11. doi: 10.1016/s1542-0124(12)70207-0. Ocul Surf. 2005. PMID: 17131029

3

A novel mouse model for neurotrophic keratopathy: trigeminal nerve stereotactic electrolysis through the brain.

Ferrari G, Chauhan SK, Ueno H, Nallasamy N, Gandolfi S, Borges L, Dana R. Ferrari G, et al. Among authors: dana r. Invest Ophthalmol Vis Sci. 2011 Apr 19;52(5):2532-9. doi: 10.1167/iovs.10-5688. Print 2011 Apr. Invest Ophthalmol Vis Sci. 2011. PMID: 21071731 Free PMC article.

4

Interferon-γ-secreting NK cells promote induction of dry eye disease.

Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Chen Y, et al. Among authors: dana r. J Leukoc Biol. 2011 Jun;89(6):965-72. doi: 10.1189/jlb.1110611. Epub 2011 Mar 14. J Leukoc Biol. 2011. PMID: 21402771 Free PMC article.

5

Dependence of corneal stem/progenitor cells on ocular surface innervation.

Ueno H, Ferrari G, Hattori T, Saban DR, Katikireddy KR, Chauhan SK, Dana R. Ueno H, et al. Among authors: dana r. Invest Ophthalmol Vis Sci. 2012 Feb 21;53(2):867-72. doi: 10.1167/iovs.11-8438. Invest Ophthalmol Vis Sci. 2012. PMID: 22232434 Free PMC article.

6

Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Barabino S, Chen Y, Chauhan S, Dana R. Barabino S, et al. Among authors: dana r. Prog Retin Eye Res. 2012 May;31(3):271-85. doi: 10.1016/j.preteyeres.2012.02.003. Epub 2012 Mar 8. Prog Retin Eye Res. 2012. PMID: 22426080 Free PMC article. Review.

7

Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).

Stevenson W, Cheng SF, Dastjerdi MH, Ferrari G, Dana R. Stevenson W, et al. Among authors: dana r. Ocul Surf. 2012 Apr;10(2):67-83. doi: 10.1016/j.jtos.2012.01.005. Epub 2012 Jan 25. Ocul Surf. 2012. PMID: 22482468 Free PMC article. Review.

8

PDE4 inhibition suppresses IL-17-associated immunity in dry eye disease.

Sadrai Z, Stevenson W, Okanobo A, Chen Y, Dohlman TH, Hua J, Amparo F, Chauhan SK, Dana R. Sadrai Z, et al. Among authors: dana r. Invest Ophthalmol Vis Sci. 2012 Jun 14;53(7):3584-91. doi: 10.1167/iovs.11-9110. Invest Ophthalmol Vis Sci. 2012. PMID: 22577075 Free PMC article.

9

Short-term topical bevacizumab in the treatment of stable corneal neovascularization.

Cheng SF, Dastjerdi MH, Ferrari G, Okanobo A, Bower KS, Ryan DS, Amparo F, Stevenson W, Hamrah P, Nallasamy N, Dana R. Cheng SF, et al. Among authors: dana r. Am J Ophthalmol. 2012 Dec;154(6):940-948.e1. doi: 10.1016/j.ajo.2012.06.007. Epub 2012 Sep 8. Am J Ophthalmol. 2012. PMID: 22967868 Free PMC article.

10

Nerves and neovessels inhibit each other in the cornea.

Ferrari G, Hajrasouliha AR, Sadrai Z, Ueno H, Chauhan SK, Dana R. Ferrari G, et al. Among authors: dana r. Invest Ophthalmol Vis Sci. 2013 Jan 28;54(1):813-20. doi: 10.1167/iovs.11-8379. Invest Ophthalmol Vis Sci. 2013. PMID: 23307967 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

492 results

Search Page